Evaluation of the Neurologic Assessment in Neuro-Oncology (NANO) criteria among brain cancer patients

Evaluation of the Neurologic Assessment in Neuro-Oncology (NANO) criteria among brain cancer patients - Evaluation of the NANO criteria

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON56677

Enrollment

Registered

2014-10-17

Start date

2014-11-01

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor glioma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: suffering from a brain tumor 18 year or older informed consent

Exclusion criteria

Exclusion criteria: not able to undergo a physical examination

Design outcomes

Primary

Measure	Time frame
Interobserver variability of the criteria of each neurologic examination domain specified in the NANO scale	—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results